Jim Cramer Blog

Discuss Hot Stocks, Jim Cramer, Mad Money,the Stock and Option Markets, and the economy on Jim Cramer Blog.

Wednesday, May 30, 2007

Biggest Stock Gainers Wednesday

Symbol
Name
Last Trade
Change
Volume
Related Info
NOVC
NOVACEA, INC.
15.00 4:00PM ET
6.94 (86.10%)
21,234,463

HDY
HYPERDYNAMICS CORP
2.14 3:59PM ET
0.54 (33.75%)
947,900

NEP
NEPHROS INC.
1.70 3:56PM ET
0.41 (31.79%)
10,200

VLNC
VALENCE TECH INC
1.38 3:59PM ET
0.30 (27.93%)
3,469,560

TCHCZ
21ST CENTURY HLDG WT
3.0899 1:58PM ET
0.5799 (23.10%)
1,277

EMIS
EMISPHERE TECH
3.95 3:59PM ET
0.67 (20.43%)
780,612

OMTL
OMTOOL LTD
1.90 3:58PM ET
0.31 (19.50%)
4,700
ESEA
EUROSEAS LTD
12.73 4:00PM ET
1.93 (17.87%)
575,112
AMCE
AMER CLAIMS EVALUA
2.05 3:55PM ET
0.31 (17.68%)
2,798

CWTR
COLDWATER CREEK
24.37 4:00PM ET
3.47 (16.60%)
15,878,548

CYTR
CYTRX CP
4.08 4:00PM ET
0.57 (16.24%)
2,370,057

CHIP
VERICHIP CORPORATION
8.00 4:00PM ET
1.08 (15.61%)
407,279

TRLG
TRUE RELIGION APPARL
17.71 4:00PM ET
2.29 (14.85%)
1,495,473

HOKU
HOKU SCIENTIFIC, INC
4.86 4:00PM ET
0.59 (13.82%)
909,891
CTU
CHAD THERAPEUTICS
2.19 3:45PM ET
0.26 (13.47%)
15,700

MEDE
MEDECISION, INC.
4.80 3:59PM ET
0.55 (12.94%)
300,127

SIR
SIRVA INC
2.71 4:02PM ET
0.27 (11.07%)
684,800
CSLMF
CONS MERCANTILE
1.22 1:59PM ET
0.12 (10.91%)
2,600

MALL
PC MALL INC
12.46 4:00PM ET
1.21 (10.76%)
175,709

HEB
HEMISPHERX BIOPHARMA
1.47 3:59PM ET
0.14 (10.53%)
389,100

Labels: , , , , , , , , , , , , , , , , , , ,

Friday, May 25, 2007

Biggest Stock Decliners Friday

Symbol
Name
Last Trade
Change
Volume
Related Info
IOMI
IOMAI CORPORATION
2.54 4:00PM ET
1.70 (40.09%)
1,028,844

SLFI
STERLING FINL CP
9.97 4:00PM ET
6.19 (38.30%)
3,294,870

MEDE
MEDECISION, INC.
4.00 3:59PM ET
0.94 (19.03%)
90,349
GSIT
GSI TECHNOLOGY INC
4.66 3:59PM ET
0.84 (15.27%)
252,227

WAVX
WAVE SYSTEMS CP CL A
2.13 3:58PM ET
0.37 (14.80%)
1,179,809

BWS
BROWN SHOE CO INC
27.76 4:04PM ET
4.39 (13.65%)
2,917,708

CPBRW
CLEARPOINT BUS WTS
0.99 2:44PM ET
0.15 (13.16%)
15,800

PRLS
PEERLESS SYSTEMS
2.5499 3:58PM ET
0.3301 (11.46%)
123,993



LTON
LINKTONE LTD.
2.71 4:00PM ET
0.29 (9.67%)
562,364

ZVUE
HANDHELD ENTERTAINMT
1.66 4:00PM ET
0.16 (8.79%)
189,523

HEM
HEMOSENSE INC.
7.85 4:00PM ET
0.75 (8.72%)
102,700
TOA
TOUSA INC
4.20 4:02PM ET
0.39 (8.50%)
1,048,580

PSIT
PSI TECH HLDGS ADS
1.78 12:21PM ET
0.16 (8.25%)
1,605
AETI
AMERICAN ELECTRIC TE
4.72 3:55PM ET
0.42 (8.17%)
38,925

JRJC
CHINA FINANCE ONLINE
9.20 3:58PM ET
0.81 (8.09%)
212,325

TSEMG
TOWER SEMICD DBS CNV
1.38 2:29PM ET
0.12 (8.00%)
2,800

ASTT
ASAT HLDGS NEW ADS
1.23 2:24PM ET
0.11 (7.93%)
6,058
CMRO
COMARCO INC
5.75 3:59PM ET
0.49 (7.85%)
22,773

Labels: , , , , , , , , , , , , , , , , ,

Symbol
Name
Last Trade
Change
Volume
Related Info
IOMI
IOMAI CORPORATION
2.54 4:00PM ET
1.70 (40.09%)
1,028,844

SLFI
STERLING FINL CP
9.97 4:00PM ET
6.19 (38.30%)
3,294,870

MEDE
MEDECISION, INC.
4.00 3:59PM ET
0.94 (19.03%)
90,349
GSIT
GSI TECHNOLOGY INC
4.66 3:59PM ET
0.84 (15.27%)
252,227

WAVX
WAVE SYSTEMS CP CL A
2.13 3:58PM ET
0.37 (14.80%)
1,179,809

BWS
BROWN SHOE CO INC
27.76 4:04PM ET
4.39 (13.65%)
2,917,708

CPBRW
CLEARPOINT BUS WTS
0.99 2:44PM ET
0.15 (13.16%)
15,800

PRLS
PEERLESS SYSTEMS
2.5499 3:58PM ET
0.3301 (11.46%)
123,993



LTON
LINKTONE LTD.
2.71 4:00PM ET
0.29 (9.67%)
562,364

ZVUE
HANDHELD ENTERTAINMT
1.66 4:00PM ET
0.16 (8.79%)
189,523

HEM
HEMOSENSE INC.
7.85 4:00PM ET
0.75 (8.72%)
102,700
TOA
TOUSA INC
4.20 4:02PM ET
0.39 (8.50%)
1,048,580

PSIT
PSI TECH HLDGS ADS
1.78 12:21PM ET
0.16 (8.25%)
1,605
AETI
AMERICAN ELECTRIC TE
4.72 3:55PM ET
0.42 (8.17%)
38,925

JRJC
CHINA FINANCE ONLINE
9.20 3:58PM ET
0.81 (8.09%)
212,325

TSEMG
TOWER SEMICD DBS CNV
1.38 2:29PM ET
0.12 (8.00%)
2,800

ASTT
ASAT HLDGS NEW ADS
1.23 2:24PM ET
0.11 (7.93%)
6,058
CMRO
COMARCO INC
5.75 3:59PM ET
0.49 (7.85%)
22,773

Labels: , , , , , , , , , , , , ,

Monday, January 08, 2007

Monday's Biggest Decliners

BioCryst Pharmaceuticals (NASDAQ:BCRX - News) named Jon Stonehouse its chief executive. BioCryst, a Birmingham, Ala., drug development company, said Stonehouse succeeds Charles Bugg, the company's founder and CEO. Bugg will become nonexecutive chairman. Stonehouse had been senior vice president of corporate development at Merck KGaA.
Caremark Rx (NYSE:CMX - News) rejected an unsolicited merger proposal from Express Scripts (NASDAQ:ESRX - News) and affirmed its support for a deal with CVS (NYSE:CVS - News).
Compucredit Corp. (NASDAQ:CCRT - News) said in a filing with the Securities and Exchange Commission that it now expects earnings for the fourth quarter to come about 20% below its previous projections.
Delta Apparel Inc. (AMEX:DLA - News) said it expects second-quarter sales of $72 million to $73 million, down from a previous estimate of $74 million to $78 million, and earnings of 5 cents to 7 cents a share, down from a prior projection of 14 cents to 18 cents a share. Delta Apparel also cut its forecast for the year's sales and earnings.
Dynavax Technologies Corp. (NASDAQ:DVAX - News) shares fell after the Berkeley, Calif.-based biotech company said interim one-year data from its two-year ragweed allergy trial indicated that "no meaningful ragweed-specific allergic disease was observed in the study population," making it impossible for the company to measure the impact of its Tolamba treatment. "This result was unexpected, though these challenges are well known to occur in allergy drug development," said Dino Dina, president and chief executive, in a statement. "Due to the fact that no clinically significant disease was seen in the study population, it was impossible to measure the effect of our intervention."
Fastenal (NASDAQ:FAST - News) was downgraded to hold from buy at BB&T Capital Markets.
Garmin (NASDAQ:GRMN - News) was downgraded to neutral from buy at D.A. Davidson due to valuation concerns.
GOL Linhas Aéreas Inteligentes (NYSE:GOL - News) said its passenger traffic rose 48% in December while its capacity rose 65% for the month, compared to the same period last year. That caused its load factor, or percentage of seats filled with paying passengers, to fall to 67.4% from 75.2%. The Brazilian low-cost airline also forecast a drop in fiscal year earnings to 3.15 to 3.30 reals a share, down from 3.40 to 3.65 reals a share.
Heartland Payment (NYSE:HPY - News) was downgraded to underweight from market weight at Thomas Weisel Partners.
Hertz (NYSE:HTZ - News) plans to cut roughly 200 jobs in the first of "a series of initiatives" to improve its competitiveness. The layoffs will come at headquarters in Park Ridge, N.J., a service center in Oklahoma City, and in U.S. field operations. The car-rental company expects to save as much as $15.8 million annually from the job cuts and expects restructuring charges of $3.3 million to $3.8 million in the first quarter.
MarineMax Inc. (NYSE:HZO - News) sees a first-quarter loss of 20 cents to 25 cents a share; the First Call-derived average forecast stands at a loss of 6 cents. The company also lowered its profit outlook for fiscal 2007.
Medecision (NASDAQ:MEDE - News) shares plunged after the Wayne, Pa.-based a provider of software and services to healthcare payers said late Friday it expects fourth-quarter revenue of $10.3 million to $10.6 million. MEDecision said it signed five contracts during the quarter, resulting in lower-than expected term license revenue of between $1.1 million and $1.3 million.
Methanex Corp. (NASDAQ:MEOH - News) was downgraded to sector underperformer from sector performer at CIBC World Markets.
Microsemi (NASDAQ:MSCC - News) was downgraded to equal weight from overweight at Lehman Bros. The firm cited a lack of catalysts for the stock.
Molex Inc. (NASDAQ:MOLX - News) lowered its second-quarter earnings and sales outlook citing lower-than-anticipated gross margins, which is due primarily to lower sales and higher price erosion in its mobile phone business. The Lisle, Ill. electronics components maker now expects to earnings of 34 to 37 cents a share vs. its previous forecast of 39 to 43 cents a share. Revenue is expected to be $830 million to $840 million, revised from a previous projection of $830 million to $850 million. The company also sees new orders slowing to $770 million to $780 million.
Myriad Genetics (NASDAQ:MYGN - News) said a clinical trial of MPC-7869, designed to evaluate its safety and potential efficacy in slowing the rate of progression of prostate cancer, didn't show statistical significance in either endpoint. The primary clinical endpoints of the trial were the time to systemic disease progression and the change in velocity of prostate specific antigen levels. The company said it does not intend to pursue further development of the compound in cancer. Myriad said it will continue to concentrate its efforts on the compound's activity in Alzheimer's disease.
Newmont Mining (NYSE:NEM - News) was downgraded to underweight from neutral weight at Prudential, which cited weak earnings power even at optimistic assumptions for metals prices. Analyst John Tumazos also lowered his stock price target to $40 from $50. "While heretofore we have 'disbelieved' how badly the company's costs deteriorated, and expected a future cost turnabout, we have given up hope in large part," Tumazos said in a research note to clients. "We expect a higher gold price outlook owing in part to higher gold mining costs and output erosion, but the profit margin at those higher prices is much lower than envisioned several years ago."
Northwest Airlines Corp. (Other OTC:NWACQ.PK - News) said traffic in December rose 1.1% to 6.38 billion revenue passenger miles. Load factor, or the percentage of the plane filled with passengers, increased by 0.7 percentage points to 80.7%. Capacity rose 0.1% to 7.9 billion available seat miles, the Eagan, Minn.-based carrier said.
Novastar Financial (NYSE:NFI - News) was downgraded to market perform from market outperform at JMP Securities.
Nu Horizons Electronics (NASDAQ:NUHC - News) said net income rose 59% to $2.4 million, or 13 cents a share, for its fiscal third quarter ended Nov. 30 with sales up 26% to $186 million. From the last quarter, however, sales fell at the electronic components distributor, due to a decline in the company's systems business related to a substantial customer-specific decrease, as well as to market weakness related to some end customer and manufacturing channel inventory builds.
Panacos Pharmaceuticals (NASDAQ:PANC - News) named Alan Dunton M.D. its new chief executive. Dunton has also been added to the company's board of directors. Dunton replaces Peyton Marshall, Panacos' chief financial officer, who had served as interim CEO since the sudden death of former Chief Executive Samuel "Skip" Ackerman last June.
P.F. Chang's China Bistro (NASDAQ:PFCB - News) was downgraded to underperform from peer perform at Bear Stearns.
Schnitzer Steel Industries (NASDAQ:SCHN - News) reported first-quarter earnings of $21 million, or 69 cents a share, down from a year-ago profit of $42 million, or $1.34 a share. The year-ago results included a gain of $34 million related to an asset disposition as well as a charge of $11 million from an investigation reserve. Excluding items, Portland, Ore.-based Schnitzer earned $19 million, or 61 cents a share, in the year-ago period. Revenue rose in the latest three months to $510 million from $341 million in the same period a year earlier. The average estimate of analysts polled by Thomson First Call was for a profit of 99 cents a share in the November period on revenue of $511.9 million. The company said it saw lower volumes and higher costs per ton in the latest quarter due to the installation of mega-shredders at its metals recycling facilities in the Oakland and Boston areas. In addition, margins were hurt by higher raw material costs in the quarter, and its auto parts business saw lower vehicle purchases due to higher prices.
Targeted Genetics Corp. (NASDAQ:TGEN - News) agreed to sell 2.18 million shares to institutional investors at a price of $4 each. The transaction includes warrants to purchase up to 763,000 shares, exercisable at price of $5.41 per share. The Seattle-based biotechnology company expects net proceeds of $8.1 million from the transaction, which is expected to close Jan. 11. Targeted Genetics plans to use the funds for working capital and general corporate purposes.
Published By MarketWatch

Labels: , , , , , , , , , , , , , , , , , , ,

Wednesday, December 13, 2006

Wednesday's Biggest Gainers

ABM Industries Inc. (NYSE:ABM - News) said fourth-quarter net income rose to $61.6 million, or $1.24 a share, from $8.43 million, or 17 cents a share, during the same period in the prior year. Quarterly revenue rose to $776.7 million from $658.7 million in the prior year. For fiscal 2007, the facility services contractor said it sees income from continuing operations of $1 to $1.05 per share, and earnings before items of $1.10 to $1.15 per share. Also, ABM's board raised the quarterly cash dividend 9% to 12 cents per share. The dividend is payable Feb. 5 to shareholders as of Jan. 12. The board has also authorized a buyback for up to two million ABM shares.
AmerisourceBergen Corp. (NYSE:ABC - News) backed its full-year 2007 profit forecast ahead of its annual investor meeting.
Amgen Inc. (NASDAQ:AMGN - News) said it has authorized the buyback of an additional $5 billion in shares. The Thousand Oaks, Calif.-based biotechnology company has $1.5 billion remaining under its previous stock repurchase authorization.
Apple Computer Inc. (NASDAQ:AAPL - News) shares rose after Morgan Stanley analyst Rebecca Runkle raised her price target on Apple's stock to $110 from $90. Runkle said new products in 2007 would add to Apple's revenue growth, and she also raised her 2007 earnings estimate for the company to $3.13 a share from $2.58.
Atlas Energy Resources (NYSE:ATN - News) shares rose in the company's initial public offering.
Atmel Corp. (NASDAQ:ATML - News) shares surged after the chipmaker said it plans to restructure its operations, which includes the sale of two factories in Europe and job cuts. "This is the restructuring announcement that investors have been patiently awaiting," wrote Wedbush Morgan analyst Craig Berger, who lifted his price target on Atmel shares to $8 and reiterated his buy rating. Atmel, in an announcement Tuesday evening, said the restructuring will slash costs by $70 million to $80 million in 2007. Approximately 1,300 employees will cut from its 8,000-person workforce worldwide. Atmel, of San Jose, Calif., makes microcontroller and radio-frequency chips used in cell phones, disk drives, car alarms, camcorders and other applications.
Buckle Inc. (NYSE:BKE - News) said its board has authorized a one-time cash dividend of $3 per share. The dividend is payable Jan. 2 to shareholders as of Dec. 22, according to the Kearney, Neb.-based retailer.
Celanese Corp. (NYSE:CE - News) said it is relocating strategic management of the company's Acetyls business to Shanghai, China, as early as spring 2007. The chemical company added that it expects to derive 45% to 55% of its earnings from Asia by 2010, compared with the current level of 30%. The company also said it expects 2007 adjusted earnings of $2.60 to $2.90 a share. That view surrounds the average analyst estimate compiled by Thomson First Call of $2.85 a share. The company also said it was reorganizing into three business groups -- advanced engineered materials, consumer and industrial specialties and acetyl intermediates -- as it moves to improve earnings and reach its target of adding $300 million to $350 million to EBITDA (earnings before interest, taxes, depreciation and amortization) growth by 2010. The company is also selling its oxo products and derivatives businesses to private equity firm Advent International for 480 million euro, or about $630 million.
CPI International (NASDAQ:CPII - News) shares rose after the Palo Alto, Calif.-based provider of microwave and radio frequency products late Tuesday reported fiscal fourth-quarter net earnings of $6.19 million, or 35 cents a share. In the same quarter last year, the company posted a net loss of $2.4 million, or 19 cents a share. Revenue rose to $82.6 million from $74.9 million. Analysts polled by Thomson First Call had forecast a per-share profit of 25 cents on revenue of $83.3 million. In fiscal 2007, CPI expects earnings of $1.24 to $1.30 a share on revenue of $350 million to $355 million.
Depomed (NASDAQ:DEPO - News) shares rose after the company said it's received a commitment for up to $30 million in common stock equity financing from Azimuth Opportunity Ltd.
Exact Sciences Corp. (NASDAQ:EXAS - News) shares leapt after the Marlborough, Mass.-based biotech company said a study of stool DNA testing found that the test demonstrated an 88% sensitivity for colorectal cancer, with equal detection across all stages, regardless of the cancer's location in the colon. The study was published online in the American Gastroenterological Association's journal, Clinical Gastroenterology and Hepatology. Exact Sciences has licensed certain of its technologies to Laboratory Corp. of America Holdings (NYSE:LH - News) for a stool-based DNA screening test.
Gander Mountain Co. (NASDAQ:GMTN - News) shares rose after the St. Paul, Minn.-based outdoor products retailer late Tuesday said David Pratt, its new chairman, has agreed to buy 5.7 million newly issued shares, for $8.77 each, for a total purchase price of $50 million. The company also said it plans to open more than a dozen new stores in fiscal 2007 and upgrade a number of existing stores.
Guidance Software Inc. (NASDAQ:GUID - News) shares surged in the company's initial public offering.
Health Net Inc. (NYSE:HNT - News) lifted its full-year 2007 earnings forecast above Wall Street's average expectation due to its share buyback program.
Home Depot (NYSE:HD - News) is taking its first steps into the China market with its acquisition of 12 home-improvement stores, the retailer said. Home Depot will buy the stores in six cities from Home Way, China's first home-improvement retailer.
IPG Photronics Corp. (NASDAQ:IPGP - News) shares leapt in the company's stock market debut.
Lumera Corp. (NASDAQ:LMRA - News) shares jumped after the Bothell, Wash.-based company reported "encouraging" results for its multi-band millimeter wave wireless bridge. Lumera said data rates from 2.5 Gbps to 10 Gbps were successfully tested and that the company expects the system will have the capacity to operate at a range of up to three miles per data link. "In the next 12 to 18 months, we will continue to improve the functionality of the system, optimize the design, and continue testing as we work to create a commercial ready product," said Dr. Raluca Dinu, director of Lumera's Electro-Optics business unit, in a statement.
Martek Biosciences (NASDAQ:MATK - News) said fourth-quarter net earnings dropped to $641,000, or 2 cents a share, compared with $4.89 million, or 15 cents a share, in the same period last year.
MEDecision Inc. (NASDAQ:MEDE - News) shares rose in the company's opening day of trading.
Midwest Air Group (AMEX:MEH - News) shares surged after AirTran Holdings Inc. (NYSE:AAI - News) unveiled an offer to buy Midwest for $290 million.
Pixelworks (NASDAQ:PXLW - News) said Allen Alley plans to resign from the president and chief executive officer positions, effective Dec. 31. Hans Olsen, currently an executive vice president and chief operating officer, will serve in both roles on an interim basis until a successor is named. The Tualatin, Ore., semiconductor maker has formed a search committee to fill the positions of president and CEO. Also, the company said it now expects revenue of $28 million to $30 million for the fourth quarter, a forecast that's within its previously disclosed outlook.
Progen Industries Ltd.'s (NASDAQ:PGLA - News) shares soared after the Australia-based pharmaceutical company announced positive preliminary results from its Phase II clinical trial of PI-88 for the treatment of patients with primary liver cancer following surgical resection of the tumor. The trial demonstrated that PI-88 increased time to tumor recurrence by 76%, the company said. "These results offer excellent support as we proceed to Phase III development, with the guidance of the FDA, as rapidly as possible," said Justus Homburg, Progen's chief executive, in a statement. Progen said it's preparing for a much larger Phase III trial of PI-88 for the treatment of liver cancer.
Tibco Software (NASDAQ:TIBX - News) shares gained after the Palo Alto, Calif., maker of business process software said it expects revenue of about $158 million for the fourth quarter, ahead of a prior projection for revenue of between $140 million and $144 million. The company expects earnings for the quarter to exceed its prior view by more than 2 cents a share.
UAL Corp. (NASDAQ:UAUA - News) and Continental Airlines (NYSE:CAL - News) are reportedly in talks about a possible merger, according to The Wall Street Journal and The New York Times.

Labels: , , , , , , , , , , , , , , , , ,

This site is not affiliated with Mr. James Cramer, and is not associated with any television networks or broadcasts. Data presented on this site should not be used to make investment decisions and accuracy cannot be guaranteed GRB Holding Co., LLC

;